Evaluation of double-disk potentiation and disk potentiation tests using dipicolinic acid for detection of metallo-β-lactamase-producing Pseudomonas spp. and Acinetobacter spp

Journal of Clinical Microbiology

Volumn 50, Issue 10, 2012, Pages 3227-3232

  Yong, Dongeun ^a   Lee, Yangsoon ^a,b   Jeong, Seok Hoon ^a   Lee, Kyungwon ^a   Chong, Yunsop ^a  

^a Yonsei University College of Medicine   (South Korea)

^b National Health Insurance Corporation   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

AGAR; ARGININE; CLOXACILLIN; DIPICOLINIC ACID; EDETIC ACID DERIVATIVE; ERTAPENEM; IMIPENEM; MACCONKEY AGAR; MEROPENEM; METALLO BETA LACTAMASE; MUELLER HINTON AGAR; PHENYLALANINE; UNCLASSIFIED DRUG;

ACINETOBACTER; AGAR DILUTION; AGAR MEDIUM; ARTICLE; BACTERIUM DETECTION; BACTERIUM ISOLATION; COMPARATIVE STUDY; CONTROLLED STUDY; DISK POTENTIATION TEST; DOUBLE DISK POTENTIATION TEST; FALSE NEGATIVE RESULT; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; OUTCOME ASSESSMENT; PRIORITY JOURNAL; PSEUDOMONAS; SENSITIVITY AND SPECIFICITY;

ACINETOBACTER; ACINETOBACTER INFECTIONS; BACTERIOLOGICAL TECHNIQUES; BETA-LACTAMASES; CULTURE MEDIA; HUMANS; PICOLINIC ACIDS; PSEUDOMONAS; PSEUDOMONAS INFECTIONS; SENSITIVITY AND SPECIFICITY;

ACINETOBACTER; PSEUDOMONAS; PSEUDOMONAS AERUGINOSA;

EID: 84866437171     PISSN: 00951137     EISSN: 1098660X     Source Type: Journal    
DOI: 10.1128/JCM.00818-12     Document Type: Article

References (21)

1. Arakawa Y, et al. 2000. Convenient test for screening metallo-β-lactamase-producing gram-negative bacteria by using thiol compounds. J. Clin. Microbiol. 38:40-43. (Pubitemid 30043261)
2. CLSI. 2008. Abbreviated identification of bacteria and yeast: approved guideline, 2nd ed. CLSI document M35-A2. Clinical and Laboratory Standards Institute, Wayne, PA.
3. CLSI. 2011. Performance standards for antimicrobial susceptibility testing; 21st informational supplement. CLSI document M100-S21. Clinical and Laboratory Standards Institute, Wayne, PA.
4. Giske CG, et al. 2011. A sensitive and specific phenotypic assay for detection of metallo-β-lactamases and KPC in Klebsiella pneumoniae with the use of meropenem disks supplemented with aminophenylboronic acid, dipicolinic acid, and cloxacillin. Clin. Microbiol. Infect. 17:552-556.
5. Hocquet D, Dehecq B, Bertrand X, Plesiat P. 2011. Strain-tailored double-disk synergy test detects extended-spectrum oxacillinases in Pseudomonas aeruginosa. J. Clin. Microbiol. 49:2262-2265.
6. Kimura S, Ishii Y, Yamaguchi K. 2005. Evaluation of dipicolinic acid for detection of IMP- or VIM-type metallo-β-lactamase-producing Pseudomonas aeruginosa clinical isolates. Diagn. Microbiol. Infect. Dis. 53:241-244. (Pubitemid 41607631)
7. Kohler T, Michea-Hamzehpour M, Epp SF, Pechere JC. 1999. Carbapenem activities against Pseudomonas aeruginosa: respective contributions of OprD and efflux systems. Antimicrob. Agents Chemother. 43:424-427. (Pubitemid 29079192)
8. Lee K, et al. 2010. Improved performance of the modified Hodge test with MacConkey agar for screening carbapenemase-producing Gram-negative bacilli. J. Microbiol. Methods 83:149-152.
9. Lee K, et al. 2009. Wide dissemination of OXA-type carbapenemases in clinical Acinetobacter spp. isolates from South Korea. Int. J. Antimicrob. Agents 33:520-524.
10. Lee K, et al. 2011. Further increases in carbapenem-, amikacin-, and fluoroquinolone-resistant isolates of Acinetobacter spp. and Pseudomonas aeruginosa in Korea: KONSAR study 2009. Yonsei Med. J. 52:793-802.
11. Lee K, Lim YS, Yong D, Yum JH, Chong Y. 2003. Evaluation of the Hodge test and the imipenem-EDTA double-disk synergy test for differentiating metallo-β-lactamase-producing isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 41:4623-4629. (Pubitemid 37259767)
12. VIM-2 allele-positive clinical isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 43:942-944.
13. SIM-1, in a class 1 integron from Acinetobacter baumannii clinical isolates from Korea. Antimicrob. Agents Chemother. 49:4485-4491.
14. Papp-Wallace KM, Endimiani A, Taracila MA, Bonomo RA. 2011. Carbapenems: past, present, and future. Antimicrob. Agents Chemother. 55:4943-4960.
15. Pitout JD, et al. 2005. Detection of Pseudomonas aeruginosa producing metallo-β-lactamases in a large centralized laboratory. J. Clin. Microbiol. 43:3129-3135. (Pubitemid 40981312)
16. Seok Y, et al. 2011. Dissemination of IMP-6 metallo-β-lactamase- producing Pseudomonas aeruginosa sequence type 235 in Korea. J. Antimicrob. Chemother. 66:2791-2796.
17. Shin KS, Son BR, Hong SB, Kim J. 2008. Dipicolinic acid-based disk methods for detection of metallo-β-lactamase-producing Pseudomonas spp. and Acinetobacter spp. Diagn. Microbiol. Infect. Dis. 62:102-105.
18. Siemann S, et al. 2002. IMP-1 metallo-β-lactamase: effect of chelators and assessment of metal requirement by electrospray mass spectrometry. Biochim. Biophys. Acta 1571:190-200. (Pubitemid 34686921)
19. OXA-51-like carbapenemase gene intrinsic to this species. J. Clin. Microbiol. 44:2974-2976.
20. Yong D, et al. 2002. Imipenem-EDTA disk method for differentiation of metallo-β-lactamase-producing clinical isolates of Pseudomonas spp. and Acinetobacter spp. J. Clin. Microbiol. 40:3798-3801.
21. OXA-23 from China. Antimicrob. Agents Chemother. 55:5347-5349.